Fibroblast growth factor receptors have different signaling and mitogenic potentials - PubMed (original) (raw)

Fibroblast growth factor receptors have different signaling and mitogenic potentials

J K Wang et al. Mol Cell Biol. 1994 Jan.

Abstract

Fibroblast growth factor (FGF) receptors (FGFRs) are structurally related receptor protein tyrosine kinases encoded by four distinct genes. Activation of FGFR-1, -2, and -3 by FGFs induces mitogenic responses in various cell types, but the mitogenic potential of FGFR-4 has not been previously explored. We have compared the properties of BaF3 murine lymphoid cells and L6 rat myoblast cells engineered to express FGFR-1 or FGFR-4. Acidic FGF binds with high affinity to and elicits tyrosine phosphorylation of FGFR-1 or FGFR-4 receptors displayed on BaF3 cells, but only FGFR-1 activation leads to cell survival and growth. FGFR-4 activation also fails to elicit detectable signals characteristic of the FGFR-1 response: tyrosine phosphorylation of SHC and extracellular signal-related kinase (ERK) proteins and induction of fos and tis11 RNA expression. The only detected response to FGFR-4 activation was weak phosphorylation of phospholipase C gamma. A chimeric receptor containing the extracellular domain of FGFR-4 and the intracellular domain of FGFR-1 confers FGF-dependent growth upon transfected BaF3 cells, demonstrating that the intracellular domains of the receptors dictate their functional capacity. Activation of FGFR-1 in transfected L6 myoblasts induced far stronger phosphorylation of phospholipase C gamma, SHC, and ERK proteins than could activation of FGFR-4 in L6 cells, and only FGFR-1 activation induced tyrosine phosphorylation of a characteristic 80-kD protein. Hence, the signaling and biological responses elicited by different FGF receptors substantially differ.

PubMed Disclaimer

Cited by

Capturing Pluripotency and Beyond.
Yeh CY, Huang WH, Chen HC, Meir YJ. Yeh CY, et al. Cells. 2021 Dec 16;10(12):3558. doi: 10.3390/cells10123558. Cells. 2021. PMID: 34944066 Free PMC article. Review.
Potential biomarkers of ductal carcinoma in situ progression.
Dettogni RS, Stur E, Laus AC, da Costa Vieira RA, Marques MMC, Santana IVV, Pulido JZ, Ribeiro LF, de Jesus Parmanhani N, Agostini LP, Dos Reis RS, de Vargas Wolfgramm Dos Santos E, Alves LNR, Garcia FM, Santos JA, do Prado Ventorim D, Reis RM, Louro ID. Dettogni RS, et al. BMC Cancer. 2020 Feb 12;20(1):119. doi: 10.1186/s12885-020-6608-y. BMC Cancer. 2020. PMID: 32050925 Free PMC article.
αKlotho-FGF23 interactions and their role in kidney disease: a molecular insight.
Smith ER, Holt SG, Hewitson TD. Smith ER, et al. Cell Mol Life Sci. 2019 Dec;76(23):4705-4724. doi: 10.1007/s00018-019-03241-y. Epub 2019 Jul 26. Cell Mol Life Sci. 2019. PMID: 31350618 Free PMC article. Review.
The Expression of Key Guidance Genes at a Forebrain Axon Turning Point Is Maintained by Distinct Fgfr Isoforms but a Common Downstream Signal Transduction Mechanism.
Yang JJ, Bertolesi GE, Dueck S, Hehr CL, McFarlane S. Yang JJ, et al. eNeuro. 2019 Apr 9;6(2):ENEURO.0086-19.2019. doi: 10.1523/ENEURO.0086-19.2019. eCollection 2019 Mar-Apr. eNeuro. 2019. PMID: 30993182 Free PMC article.
Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity.
Agrawal A, Parlee S, Perez-Tilve D, Li P, Pan J, Mroz PA, Kruse Hansen AM, Andersen B, Finan B, Kharitonenkov A, DiMarchi RD. Agrawal A, et al. Mol Metab. 2018 Jul;13:45-55. doi: 10.1016/j.molmet.2018.05.003. Epub 2018 May 11. Mol Metab. 2018. PMID: 29789271 Free PMC article.

References

1. EMBO J. 1990 Sep;9(9):2685-92 - PubMed
1. Mol Cell Biol. 1990 Sep;10(9):4770-7 - PubMed
1. Science. 1991 Jan 4;251(4989):72-5 - PubMed
1. Neuron. 1990 Dec;5(6):757-66 - PubMed
1. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1095-9 - PubMed

Fibroblast growth factor receptors have different signaling and mitogenic potentials - PubMed (original) (raw)